The prognostic value and mechanisms of lncRNA UCA1 in human cancer

References

• Torre LA, Freddie B, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):69–90. doi:10.3322/caac.21262
   Web of Science ®Google Scholar
• Koo MM, Hamilton W, Walter FM, et al. Symptom signatures and diagnostic timeliness in cancer patients: a review of current evidence. Neoplasia. 2018;20(2):165–174. doi:10.1016/j.neo.2017.11.00529253839
   PubMed Web of Science ®Google Scholar
• Nie J, Zhao C, Deng LI, et al. Efficacy of traditional Chinese medicine in treating cancer. Biomed Rep. 2016;4(1):3–14. doi:10.3892/br.2015.53726870326
   PubMed Web of Science ®Google Scholar
• Nakashima L. Evolution of cancer treatment and evolving challenges. Healthc Manage Forum. 2018;31(1):26–28. doi:10.1177/084047041772256829264971
   PubMedGoogle Scholar
• Hajjari M, Khoshnevisan A, Shin YK. Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer. Tumor Biol. 2014;35(11):10645–10663. doi:10.1007/s13277-014-2636-z
   PubMedGoogle Scholar
• Tang Y, Cheung BB, Atmadibrata B, et al. The regulatory role of long noncoding RNAs in cancer. Cancer Lett. 2017;391:12–19. doi:10.1016/j.canlet.2017.01.01028111137
   PubMed Web of Science ®Google Scholar
• Guo H, Huang S, Li S, et al. Prognostic significance of the long noncoding RNAs in nasopharyngeal carcinoma: a systematic review and meta-analysis. Cancer Manag Res. 2018;10:1763–1779. doi:10.2147/CMAR.S16469529988744
   PubMed Web of Science ®Google Scholar
• Iakes E, David J, Jose Manuel R, et al. Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes. Hum Mol Genet. 2014;23(22):5866–5878. doi:10.1093/hmg/ddu30924939910
   PubMed Web of Science ®Google Scholar
• Yamamura S, Imai-Sumida M, Tanaka Y, et al. Interaction and cross-talk between non-coding RNAs. Cell Mol Life Sci. 2018;75(3):467–484. doi:10.1007/s00018-017-2626-628840253
   PubMed Web of Science ®Google Scholar
• Yang S, Sun Z, Zhou Q, et al. MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer. Cancer Manag Res. 2018;10:2249–2257. doi:10.2147/CMAR.S16630830100756
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2015;17(1):47–62. doi:10.1038/nrg.2015.10
   Web of Science ®Google Scholar
• Schmitt A, Chang H. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463. doi:10.1016/j.ccell.2016.03.01027070700
   PubMed Web of Science ®Google Scholar
• Huang J, Zhou N, Watabe K, et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis. 2014;5(1):e1008. doi:10.1038/cddis.2013.54124457952
   PubMedGoogle Scholar
• Wang X, Fa XE. Knockdown of UCA1 inhibits viability and glycolysis by suppressing PKM2 expression through the mTOR pathway in non-small cell lung cancer cells. RSC Adv. 2018;8(19):10610–10619. doi:10.1039/C8RA00860D
   PubMed Web of Science ®Google Scholar
• Xie XJ, Xu LI, Wang F. Cellular localization and tissue expression pattern of UCA1, a non-coding RNA. J South Med Univ. 2010;30(1):57–60. doi:10.3724/SP.J.1008.2010.01244
   Google Scholar
• Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006;12(16):4851–4858. doi:10.1158/1078-0432.CCR-06-013416914571
   PubMed Web of Science ®Google Scholar
• Xue M, Chen W, Li X. Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. J Cancer Res Clin Oncol. 2016;142(7):1–13. doi:10.1007/s00432-015-2042-y25644862
   PubMed Web of Science ®Google Scholar
• Yazarlou F, Modarressi MH, Mowla SJ, et al. Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer. Cancer Manag Res. 2018;10:6357–6365. doi:10.2147/CMAR.S18610830568497
   PubMed Web of Science ®Google Scholar
• Li Z, Dou P, Liu T, He S. Application of long noncoding RNAs in osteosarcoma: biomarkers and therapeutic targets. Cell Physiol Biochem. 2017;42(4):1407–1419. doi:10.1159/00047920528715796
   PubMed Web of Science ®Google Scholar
• Sun XD, Chen H, Wei Q, et al. Clinical significance of UCA1 to predict metastasis and poor prognosis of digestive system malignancies: a meta-analysis. Gastroenterol Res Pract. 2016;2016(1):1–11. doi:10.1155/2016/3729830
   Google Scholar
• Song W, Gobe GC. Understanding molecular pathways and targets of Brachyury in epithelial-mesenchymal transition (EMT) in human cancers. Curr Cancer Drug Targets. 2016;16(7):586–593. doi:10.2174/156800961666616032811333827018266
   PubMed Web of Science ®Google Scholar
• Chen YC, Statt S, Wu R, et al. High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci Rep. 2016;6:18815. doi:10.1038/srep1881526739898
   PubMed Web of Science ®Google Scholar
• Xue M, Pang H, Li X, et al. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci. 2016;107(1):18–27. doi:10.1111/cas.1284426544536
   PubMed Web of Science ®Google Scholar
• Luo J, Chen J, Li H, et al. LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway. Oncol Lett. 2017;14(5):5556–5562. doi:10.3892/ol.2017.688629113184
   PubMed Web of Science ®Google Scholar
• Gou L, Liu M, Xia J, et al. BMP9 promotes the proliferation and migration of bladder cancer cells through up-regulating lncRNA UCA1. Int J Mol Sci. 2018;19(4):1116. doi:10.3390/ijms19041116
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pier Paolo P. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi:10.1038/nature1298624429633
   PubMed Web of Science ®Google Scholar
• Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358–369. doi:10.1016/j.cell.2011.09.02822000014
   PubMed Web of Science ®Google Scholar
• Zhao G, Fu Y, Su Z, et al. How long non-coding RNAs and microRNAs mediate the endogenous RNA network of head and neck squamous cell carcinoma: a comprehensive analysis. Cell Physiol Biochem. 2018;50(1):332–341. doi:10.1159/00049400930282065
   PubMedGoogle Scholar
• Zheng C, Li X, Qian B, et al. The lncRNA myocardial infarction associated transcript-centric competing endogenous RNA network in non-small-cell lung cancer. Cancer Manag Res. 2018;10:1155–1162. doi:10.2147/CMAR.S16339529795987
   PubMed Web of Science ®Google Scholar
• Bian Z, Jin L, Zhang J, et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep. 2016;6:23892. doi:10.1038/srep2389227046651
   PubMed Web of Science ®Google Scholar
• Ni B, Yu X, Guo X, et al. Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol. 2015;47(4):1329–1338. doi:10.3892/ijo.2015.310926238511
   PubMed Web of Science ®Google Scholar
• Li C, Liang G, Yang S, et al. Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway. Oncotarget. 2017;8(55):93476–93491. doi:10.18632/oncotarget.1928129212166
   PubMedGoogle Scholar
• Qin L, Jia Z, Xie D, Liu Z. Knockdown of long noncoding RNA urothelial carcinoma-associated 1 inhibits cell viability, migration, and invasion by regulating microRNA-182 in gastric carcinoma. J Cell Biochem. 2018;119(12):10075–10086. doi:10.1002/jcb.2734430129054
   PubMed Web of Science ®Google Scholar
• Gong P, Qiao F, Wu H, et al. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer. Cell Death Dis. 2018;9(12):1158. doi:1038/s41419-018-1170-030464170
   PubMed Web of Science ®Google Scholar
• Gu L, Lu LS, Zhou DL, et al. UCA1 promotes cell proliferation and invasion of gastric cancer by targeting CREB1 sponging to miR-590-3p. Cancer Med. 2018;7(4):1253–1263. doi:10.1002/cam4.131029516678
   PubMed Web of Science ®Google Scholar
• Li J, Gao J, Kan A, et al. SNHG and UCA1 as prognostic molecular biomarkers in hepatocellular carcinoma: recent research and meta-analysis. Minerva Med. 2017;108(6):568–574. doi:10.23736/S0026-4806.17.05094-728466631
   PubMed Web of Science ®Google Scholar
• Qin LT, Tang RX, Lin P, et al. Biological function of UCA1 in hepatocellular carcinoma and its clinical significance: investigation with in vitro and meta-analysis. Pathol Res Pract. 2018;214(9):1260–1272. doi:10.1016/j.prp.2018.03.02530017333
   PubMed Web of Science ®Google Scholar
• Wang F, Ying HQ, He BS, et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget. 2015;6(10):7899–7917. doi:10.18632/oncotarget.321925760077
   PubMedGoogle Scholar
• Xiao JN, Yan TH, Yu RM, et al. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression. J Cancer Res Clin Oncol. 2017;143(6):981–990. doi:10.1007/s00432-017-2370-128271214
   PubMed Web of Science ®Google Scholar
• Liu H, Wang G, Yang L, et al. Knockdown of long non-coding RNA UCA1 increases the tamoxifen sensitivity of breast cancer cells through inhibition of Wnt/β-catenin pathway. PLOS One. 2016;11(12):e0168406. doi:10.1371/journal.pone.016840627977766
   PubMed Web of Science ®Google Scholar
• Wu C, Luo J. Long non-coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) enhances tamoxifen resistance in breast cancer cells via inhibiting mTOR signaling pathway. Med Sci Monit. 2016;22:3860–3867. doi:10.12659/msm.90068927765938
   PubMed Web of Science ®Google Scholar
• Zhu HY, Bai WD, Ye XM, et al. Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1. Biochem Biophys Res Commun. 2018;496(4):1308–1313. doi:10.1016/j.bbrc.2018.02.00629408336
   PubMed Web of Science ®Google Scholar
• Jiao C, Song Z, Chen J, et al. lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer. Oncol Rep. 2016;36(5):2960–2966. doi:10.3892/or.2016.512127667646
   PubMed Web of Science ®Google Scholar
• Du Z, Sun T, Hacisuleyman E, et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 2016;7:10982. doi:10.1038/ncomms1098226975529
   PubMed Web of Science ®Google Scholar
• Nie W, Ge HJ, Yang XQ, et al. LncRNA- UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett. 2016;371(1):99–106. doi:10.1016/j.canlet.2015.11.02426655272
   PubMed Web of Science ®Google Scholar
• Wu H, Zhou C. Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axis. Biochem Biophys Res Commun. 2018;496(2):738–745. doi:10.1016/j.bbrc.2018.01.09729355524
   PubMed Web of Science ®Google Scholar
• Wang X, Yang B, Ma B. The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells. Cancer Chemother Pharmacol. 2016;78(5):1025–1031. doi:10.1007/s00280-016-3158-827686228
   PubMed Web of Science ®Google Scholar
• Fotouhi GA, Taeb S, Huang X, et al. Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer. Oncotarget. 2016;8(3):4668–4689. doi:10.18632/oncotarget.13576
   Google Scholar
• Zhang X, Gao F, Zhou L, et al. UCA1 regulates the growth and metastasis of pancreatic cancer by sponging MiR-135a. Oncol Res. 2017;25(9):1529–1541. doi:10.3727/096504017X1488898768315228315290
   PubMed Web of Science ®Google Scholar
• Zhou Y, Chen Y, Ding W, et al. LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR-96/FOXO3. IUBMB Life. 2018;70(4):276–290. doi:10.1002/iub.169929500870
   PubMed Web of Science ®Google Scholar
• Chen P, Wan D, Zheng D, et al. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer. Biomed Pharmacother. 2016;83:1220–1226. doi:10.1016/j.biopha.2016.08.04127562722
   PubMed Web of Science ®Google Scholar
• Zhang L, Cao X, Zhang L, Zhang X, Sheng H, Tao K. UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy. Cancer Chemother Pharmacol. 2016;77(3):629–634. doi:10.1007/s00280-016-2963-426851957
   PubMed Web of Science ®Google Scholar
• Wang J, Ye C, Liu J, Hu Y. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Biochem Biophys Res Commun. 2018;501(4):1034–1040. doi:10.1016/j.bbrc.2018.05.10429777711
   PubMed Web of Science ®Google Scholar
• Fang Z, Wu L, Wang L, Yang Y, Meng Y, Yang H. Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(1):89–95. doi:10.1016/j.oooo.2013.09.00724332332
   PubMed Web of Science ®Google Scholar
• Zhang TH, Liang LZ, Liu XL, et al. LncRNA UCA1/miR-124 axis modulates TGFβ1-induced epithelial-mesenchymal transition and invasion of tongue cancer cells through JAG1/Notch signaling. J Cell Biochem. 2019;120(6):10495–10504. doi:10.1002/jcb.28334
   Google Scholar
• Tian Y, Zhang X, Hao Y, Fang Z, He Y. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res. 2014;24(4):335–341. doi:10.1097/CMR.000000000000008024892958
   PubMed Web of Science ®Google Scholar
• Wei Y, Sun Q, Zhao L, et al. LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma. Med Oncol. 2016;33(8):88. doi:10.1007/s12032-016-0804-227389544
   PubMed Web of Science ®Google Scholar
• Lu HW, Liu XD. UCA1 promotes papillary thyroid carcinoma development by stimulating cell proliferation via Wnt pathway. Eur Rev Med Pharmacol Sci. 2018;22(17):5576–5582. doi:10.26355/eurrev_201809_1582130229831
   PubMed Web of Science ®Google Scholar
• Liu H, Li R, Guan L, Jiang T. Knockdown of lncRNA UCA1 inhibits proliferation and invasion of papillary thyroid carcinoma through regulating miR-204/IGFBP5 axis. Onco Targets Ther. 2018;11:7197–7204. doi:10.2147/OTT.S17546730425512
   PubMed Web of Science ®Google Scholar
• Zhu G, Liu X, Su Y, Kong F, Hong X, Lin Z. Knockdown of Urothelial Carcinoma-Associated 1 suppressed cell growth and migration through regulating miR-301a and CXCR4 in osteosarcoma MHCC97 cells. Oncol Res. 2018;27(1):55–64. doi:10.3727/096504018X1520114370585529523218
   PubMed Web of Science ®Google Scholar
• Li T, Xiao Y, Huang T. HIF-1α-induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway. Oncol Rep. 2018;39(3):1072–1080. doi:10.3892/or.2018.618229328452
   PubMed Web of Science ®Google Scholar
• Sun Y, Jin JG, Mi WY, Zhang SR, Meng Q, Zhang ST. Long noncoding RNA UCA1 targets miR-122 to promote proliferation, migration, and invasion of glioma cells. Oncol Res. 2018;26(1):103–110. doi:10.3727/096504017X1493486012286428548636
   PubMed Web of Science ®Google Scholar
• He Z, Wang Y, Huang G, Wang Q, Zhao D, Chen L. The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP. Arch Biochem Biophys. 2017;623–624:1–8. doi:10.1016/j.abb.2017.01.013
   PubMed Web of Science ®Google Scholar
• Zhang ZS, Wang J, Zhu BQ, Ge L. Long noncoding RNA UCA1 promotes multiple myeloma cell growth by targeting TGF-β. Eur Rev Med Pharmacol Sci. 2018;22(5):1374–1379. doi:10.26355/eurrev_201803_1448129565496
   PubMed Web of Science ®Google Scholar
• Yang YT, Wang YF, Lai JY, et al. Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway. Cancer Sci. 2016;107(11):1581–1589. doi:10.1111/cas.1305827560546
   PubMed Web of Science ®Google Scholar
• Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Cancer Med. 2017;6(12):2897–2908. doi:10.1002/cam4.125329125238
   PubMed Web of Science ®Google Scholar
• Yan Q, Tian Y, Hao F. Downregulation of lncRNA UCA1 inhibits proliferation and invasion of cervical cancer cells through miR-206 expression. Oncol Res. 2018. doi:10.3727/096504018X15185714083446
   Google Scholar
• Fan L, Huang C, Li J, Gao T, Lin Z, Yao T. Long noncoding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer. Int J Mol Med. 2018;42(4):2247–2259. doi:10.3892/ijmm.2018.377830015920
   PubMed Web of Science ®Google Scholar
• Pang A, Carbini M, Moreira AL, et al. Carcinosarcomas and related cancers: tumors caught in the act of epithelial-mesenchymal transition. J Clin Oncol. 2017;36(2):210–216. doi:10.1200/JCO.2017.74.952329220296
   PubMed Web of Science ®Google Scholar
• Feng G, Kazuko H, Sen-Itiroh H. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci U S A. 2009;106(18):7461–7466. doi:10.1073/pnas.090236810619380734
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu WZ, Liu T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600–604. doi:10.3109/10799893.2015.103041226096166
   PubMed Web of Science ®Google Scholar
• Dienstmann R, Rodon J, Prat A, et al. Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors. Ann Oncol. 2014;25(3):552–563. doi:10.1093/annonc/mdu20324265351
   PubMed Web of Science ®Google Scholar
• Xiao C, Wu CH, Hu HZ. LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2016;20(13):2819–2824.27424981
   PubMed Web of Science ®Google Scholar
• Hu JJ, Song W, Zhang SD, et al. HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Sci Rep. 2016;6:23521. doi:10.1038/srep2352127009634
   PubMed Web of Science ®Google Scholar
• Lee JJ, Kim M, Kim HP. Epigenetic regulation of long noncoding RNA UCA1 by SATB1 in breast cancer. BMB Rep. 2016;49(10):578–583.doi:10.5483/bmbrep.2016.49.10.15627697109
   PubMed Web of Science ®Google Scholar
• Wang ZQ, Cai Q, Hu L, et al. Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer. Cell Death Dis. 2017;8(6):e2839. doi:10.1038/cddis.2017.51828569779
   PubMed Web of Science ®Google Scholar
• Ge M, Liu H, Zhang Y, et al. The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy. Br J Pharmacol. 2017;174(10):1147–1160. doi:10.1111/bph.1376628257144
   PubMed Web of Science ®Google Scholar
• Hiemer SE, Szymaniak AD, Varelas X. The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells. J Biol Chem. 2014;289(19):13461–13474. doi:10.1074/jbc.M113.52911524648515
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao Y, Zhang Y, et al. LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5 Pt A):1770–1782. doi:10.1016/j.bbadis.2018.03.00529510195
   PubMed Web of Science ®Google Scholar